These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 8274455

  • 21. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
    Chang FL, Ling YF, Lai MD.
    Anticancer Res; 2000; 20(1A):329-36. PubMed ID: 10769676
    [Abstract] [Full Text] [Related]

  • 22. Analysis of the tumor suppressor activity of the K-rev-1 gene in human tumor cell lines.
    Sato KY, Polakis PG, Haubruck H, Fasching CL, McCormick F, Stanbridge EJ.
    Cancer Res; 1994 Jan 15; 54(2):552-9. PubMed ID: 8275494
    [Abstract] [Full Text] [Related]

  • 23. Malignant transformation of rat embryo fibroblasts by cotransfection with eleven human mutant p53 cDNAs and activated H-ras gene.
    Kikuchi-Yanoshita R, Tanaka K, Muraoka M, Konishi M, Kawashima I, Takamoto S, Hirai H, Miyaki M.
    Oncogene; 1995 Oct 05; 11(7):1339-45. PubMed ID: 7478555
    [Abstract] [Full Text] [Related]

  • 24. Transfection of wild-type but not mutant p53 induces early monocytic differentiation in HL60 cells and increases their sensitivity to stress.
    Banerjee D, Lenz HJ, Schnieders B, Manno DJ, Ju JF, Spears CP, Hochhauser D, Danenberg K, Danenberg P, Bertino JR.
    Cell Growth Differ; 1995 Nov 05; 6(11):1405-13. PubMed ID: 8562479
    [Abstract] [Full Text] [Related]

  • 25. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, Pierotti MA, Miyashita T, Reed JC, Zunino F.
    Cancer Res; 1996 Feb 01; 56(3):556-62. PubMed ID: 8564971
    [Abstract] [Full Text] [Related]

  • 26. Different p53 mutations produce distinct effects on the ability of colon carcinoma cells to become blocked at the G1/S boundary after irradiation.
    Pocard M, Chevillard S, Villaudy J, Poupon MF, Dutrillaux B, Remvikos Y.
    Oncogene; 1996 Feb 15; 12(4):875-82. PubMed ID: 8632910
    [Abstract] [Full Text] [Related]

  • 27. A novel host cell reactivation assay to assess homologous recombination capacity in human cancer cell lines.
    Slebos RJ, Taylor JA.
    Biochem Biophys Res Commun; 2001 Feb 16; 281(1):212-9. PubMed ID: 11178982
    [Abstract] [Full Text] [Related]

  • 28. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines.
    Janicek MF, Angioli R, Unal AD, Sevin BU, Madrigal M, Estape R, Averette HE.
    Gynecol Oncol; 1997 Jul 16; 66(1):94-102. PubMed ID: 9234928
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. H-, K- and N-Ras inhibit myeloid leukemia cell proliferation by a p21WAF1-dependent mechanism.
    Delgado MD, Vaqué JP, Arozarena I, López-Ilasaca MA, Martínez C, Crespo P, León J.
    Oncogene; 2000 Feb 10; 19(6):783-90. PubMed ID: 10698496
    [Abstract] [Full Text] [Related]

  • 31. Analysis of p53 transactivation through high-affinity binding sites.
    Chumakov AM, Miller CW, Chen DL, Koeffler HP.
    Oncogene; 1993 Nov 10; 8(11):3005-11. PubMed ID: 8414502
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Analysis of p53 status in human cell lines using a functional assay in yeast: detection of new non-sense p53 mutation in codon 124.
    Smardová J, Pavlová S, Svitáková M, Grochová D, Ravcuková B.
    Oncol Rep; 2005 Oct 10; 14(4):901-7. PubMed ID: 16142349
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis.
    Gomez-Manzano C, Fueyo J, Kyritsis AP, Steck PA, Roth JA, McDonnell TJ, Steck KD, Levin VA, Yung WK.
    Cancer Res; 1996 Feb 15; 56(4):694-9. PubMed ID: 8630997
    [Abstract] [Full Text] [Related]

  • 36. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
    Spitkovsky D, Aengeneyndt F, Braspenning J, von Knebel Doeberitz M.
    Oncogene; 1996 Sep 05; 13(5):1027-35. PubMed ID: 8806692
    [Abstract] [Full Text] [Related]

  • 37. Suppression of various human tumor cell lines by a dominant negative H-ras mutant.
    Ogiso Y, Sakai N, Watari H, Yokoyama T, Kuzumaki N.
    Gene Ther; 1994 Nov 05; 1(6):403-7. PubMed ID: 7584106
    [Abstract] [Full Text] [Related]

  • 38. Human wild-type p53 adopts a unique conformational and phosphorylation state in vivo during growth arrest of glioblastoma cells.
    Ullrich SJ, Mercer WE, Appella E.
    Oncogene; 1992 Aug 05; 7(8):1635-43. PubMed ID: 1630823
    [Abstract] [Full Text] [Related]

  • 39. Melanoma cells can tolerate high levels of transcriptionally active endogenous p53 but are sensitive to retrovirus-transduced p53.
    Kichina JV, Rauth S, Das Gupta TK, Gudkov AV.
    Oncogene; 2003 Jul 31; 22(31):4911-7. PubMed ID: 12894234
    [Abstract] [Full Text] [Related]

  • 40. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells.
    Katayose D, Gudas J, Nguyen H, Srivastava S, Cowan KH, Seth P.
    Clin Cancer Res; 1995 Aug 31; 1(8):889-97. PubMed ID: 9816059
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.